Literature DB >> 24618551

Pulmonary arterial remodeling in chronic obstructive pulmonary disease is lobe dependent.

Jeremy P Wrobel1, Catriona A McLean, Bruce R Thompson, Christopher R Stuart-Andrews, Eldho Paul, Gregory I Snell, Trevor J Williams.   

Abstract

Abstract Pulmonary arterial remodeling has been demonstrated in patients with severe chronic obstructive pulmonary disease (COPD), but it is not known whether lobar heterogeneity of remodeling occurs. Furthermore, the relationship between pulmonary hypertension (PH) and pulmonary arterial remodeling in COPD has not been established. Muscular pulmonary arterial remodeling in arteries 0.10-0.25 mm in diameter was assessed in COPD-explanted lungs and autopsy controls. Remodeling was quantified as the percentage wall thickness to vessel diameter (%WT) using digital image analysis. Repeat measures mixed-effects remodeling for %WT was performed according to lobar origin (upper and lower), muscular pulmonary arterial size (small, medium, and large), and echocardiography-based pulmonary arterial pressure (no PH, mild PH, and moderate-to-severe PH). Lobar perfusion and emphysema indices were determined from ventilation-perfusion and computed tomography scans, respectively. Overall, %WT was greater in 42 subjects with COPD than in 5 control subjects ([Formula: see text]). Within the COPD group, %WT was greater in the upper lobes ([Formula: see text]) and in the small muscular pulmonary arteries ([Formula: see text]). Lobar differences were most pronounced in medium and large arteries. Lobar emphysema index was not associated with arterial remodeling. However, there was a significant positive relationship between the lobar perfusion index and pulmonary arterial remodeling ([Formula: see text]). The presence of PH on echocardiography showed only a trend to a small effect on lower lobe remodeling. The pattern of pulmonary arterial remodeling in COPD is complicated and lobe dependent. Differences in regional blood flow partially account for the lobar heterogeneity of pulmonary arterial remodeling in COPD.

Entities:  

Year:  2013        PMID: 24618551      PMCID: PMC4070801          DOI: 10.1086/674339

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  40 in total

1.  The pulmonary circulation in chronic bronchitis and emphysema.

Authors:  D M Shelton; E Keal; L Reid
Journal:  Chest       Date:  1977-02       Impact factor: 9.410

2.  Assessment of the effects of age and smoking on the media of muscular pulmonary arteries.

Authors:  J M Fernie; D Lamb
Journal:  J Pathol       Date:  1988-07       Impact factor: 7.996

3.  Muscularity of pulmonary artery branches in the upper and lower lobes of the normal young and aged lung.

Authors:  P Simons; L Reid
Journal:  Br J Dis Chest       Date:  1969-01

4.  Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema.

Authors:  K A Hale; D E Niewoehner; M G Cosio
Journal:  Am Rev Respir Dis       Date:  1980-08

5.  Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease.

Authors:  D Sajkov; R D McEvoy; R J Cowie; J A Bradley; R Antic; R G Morris; P A Frith
Journal:  Chest       Date:  1993-05       Impact factor: 9.410

6.  Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index.

Authors:  David S Gierada; Andrew J Bierhals; Cliff K Choong; Seth T Bartel; Jon H Ritter; Nitin A Das; Cheng Hong; Thomas K Pilgram; Kyongtae T Bae; Bruce R Whiting; Jason C Woods; James C Hogg; Barbara A Lutey; Richard J Battafarano; Joel D Cooper; Bryan F Meyers; G Alexander Patterson
Journal:  Acad Radiol       Date:  2010-02       Impact factor: 3.173

7.  Ventilation-perfusion inequality in chronic obstructive pulmonary disease.

Authors:  P D Wagner; D R Dantzker; R Dueck; J L Clausen; J B West
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

8.  "Density mask". An objective method to quantitate emphysema using computed tomography.

Authors:  N L Müller; C A Staples; R R Miller; R T Abboud
Journal:  Chest       Date:  1988-10       Impact factor: 9.410

9.  Significance of pulmonary artery pressure in emphysema patients with mild-to-moderate hypoxemia.

Authors:  Mihoko Doi; Kikuo Nakano; Takehiko Hiramoto; Nobuoki Kohno
Journal:  Respir Med       Date:  2003-08       Impact factor: 3.415

10.  Lung disease in long-term cigarette smokers with and without chronic air-flow obstruction.

Authors:  K A Hale; S L Ewing; B A Gosnell; D E Niewoehner
Journal:  Am Rev Respir Dis       Date:  1984-11
View more
  5 in total

1.  Mutual promotion of FGF21 and PPARγ attenuates hypoxia-induced pulmonary hypertension.

Authors:  Gexiang Cai; Jingjing Liu; Meibin Wang; Lihuang Su; Mengsi Cai; Kate Huang; Xiuchun Li; Manxiang Li; Liangxing Wang; Xiaoying Huang
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-02

2.  Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI-Same Same but Different?

Authors:  Elke Boxhammer; Moritz Mirna; Laura Bäz; Brunilda Alushi; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

3.  Etanercept Protected Against Cigarette Smoke Extract-Induced Inflammation and Apoptosis of Human Pulmonary Artery Endothelial Cells via Regulating TNFR1.

Authors:  Hong Xue; Baosong Xie; Nengluan Xu; Hongru Li; Qianshun Chen; Weiping Xie; Hong Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-11

4.  Right heart functional changes in the acute, hypercapnic exacerbations of COPD.

Authors:  Claudio Terzano; Sofia Romani; Carlo Gaudio; Francesco Pelliccia; Mattia Serao; Antonio Vitarelli
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

Review 5.  Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?

Authors:  Florence Coste; Ilyes Benlala; François Laurent; Patrick Berger; Gaël Dournes; Pierre-Olivier Girodet
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.